Publication: Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC.
No Thumbnail Available
Date
2023-07-13
Authors
Authors
TÜRK, HACI MEHMET
Tsuboi M.
Herbst R. S.
John T.
Kato T.
Majem M.
Grohé C.
Wang J.
Goldman J. W.
Lu S.
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Description
Keywords
Citation
Tsuboi M., Herbst R. S., John T., Kato T., Majem M., Grohé C., Wang J., Goldman J. W., Lu S., Su W., et al., "Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC.", The New England journal of medicine, cilt.389, sa.2, ss.137-147, 2023